Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China flag China · Delayed Price · Currency is CNY
29.89
-0.36 (-1.19%)
Oct 30, 2026, 3:04 PM CST

SHE:002294 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,095968.431,1251,3222,6703,236
Short-Term Investments
279.841,433988.85695.51531.58-
Trading Asset Securities
499.81688.98733.86186.06328.3660
Cash & Short-Term Investments
1,8753,0912,8482,2043,5303,296
Cash Growth
-22.57%8.52%29.25%-37.58%7.12%205.25%
Accounts Receivable
887.14850.55565.87545.38557.72474.03
Other Receivables
18.6330.8723.8521.0123.4155.48
Receivables
905.77881.42589.72566.39581.12629.51
Inventory
576.11548.19506.76490.86543.53420.45
Other Current Assets
630.2262.5380.0252.4356.3658
Total Current Assets
3,9874,5834,0253,3134,7114,404
Property, Plant & Equipment
1,5551,5321,4301,4571,5061,638
Long-Term Investments
553.54907.011,4921,701963.07854.48
Goodwill
219.49219.4910.9110.9160.5387.14
Other Intangible Assets
1,3341,4111,3351,318965.461,048
Long-Term Deferred Tax Assets
244.05215.64151.2487.488.4282.01
Long-Term Deferred Charges
2,4151,9961,5971,4161,3441,047
Other Long-Term Assets
925.18433.8424.7793.31116.6483.09
Total Assets
11,23311,29810,4669,3979,7559,244

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
186.73184.79126.09156.01219.65187.67
Accrued Expenses
237.85906.58716.68491.34558.35487.02
Short-Term Debt
302.57263.3412040177.1963
Current Portion of Leases
-5.869.710.9311.466.99
Current Income Taxes Payable
91.8325.967.1510.4928.9237.2
Current Unearned Revenue
51.248.9439.3529.5542.6697.99
Other Current Liabilities
741.93578.569476.77565.4132.98
Total Current Liabilities
1,6122,0141,113815.081,6041,013
Long-Term Debt
607-----
Long-Term Leases
17.9320.984.1812.5419.589.11
Long-Term Unearned Revenue
176.45149.12142.0484.1198.5393.71
Long-Term Deferred Tax Liabilities
29.4632.1620.9713.0427.18-
Other Long-Term Liabilities
-27.54433.14416.4729.6482.57
Total Liabilities
2,4432,2441,7131,3411,7791,198

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,1151,1151,1151,1151,1151,115
Additional Paid-In Capital
2,0832,0811,9281,9001,8661,930
Retained Earnings
5,7515,7205,6205,5645,5295,330
Treasury Stock
-266.25---602.16-602.16-327.86
Comprehensive Income & Other
-16.8116.8549.342.2233.24-13.41
Total Common Equity
8,6668,9338,7128,0197,9418,034
Minority Interest
123.66120.8440.1736.4335.8111.91
Shareholders' Equity
8,7909,0548,7528,0557,9778,046
Total Liabilities & Equity
11,23311,29810,4669,3979,7559,244

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
927.51290.19133.8863.47208.2379.1
Net Cash (Debt)
947.62,8012,7142,1403,3223,217
Net Cash Growth
-56.50%3.18%26.83%-35.58%3.28%366.56%
Net Cash Per Share
0.852.492.441.923.023.01
Filing Date Shares Outstanding
1,1061,1151,1151,0911,0911,103
Total Common Shares Outstanding
1,1061,1151,1151,0911,0911,103
Working Capital
2,3752,5692,9122,4983,1083,391
Book Value Per Share
7.838.017.817.357.287.29
Tangible Book Value
7,1137,3037,3666,6906,9156,898
Tangible Book Value Per Share
6.436.556.616.136.346.26
Buildings
-1,2661,2221,2181,2081,218
Machinery
-1,3211,2581,2031,1381,109
Construction In Progress
-173.3262.3334.3537.694.13